[go: up one dir, main page]

ES8705466A1 - Human endogenous cancer regulatory factors. - Google Patents

Human endogenous cancer regulatory factors.

Info

Publication number
ES8705466A1
ES8705466A1 ES550833A ES550833A ES8705466A1 ES 8705466 A1 ES8705466 A1 ES 8705466A1 ES 550833 A ES550833 A ES 550833A ES 550833 A ES550833 A ES 550833A ES 8705466 A1 ES8705466 A1 ES 8705466A1
Authority
ES
Spain
Prior art keywords
regulatory factors
human endogenous
endogenous cancer
cancer regulatory
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550833A
Other languages
Spanish (es)
Other versions
ES550833A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES8705466A1 publication Critical patent/ES8705466A1/en
Publication of ES550833A0 publication Critical patent/ES550833A0/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Human endogenous cancer regulatory factors useful as anti-tumor agents having a molecular weight in the range from 17,000 to 30,000, and pharmaceutical compositions containing the same. The low-molecular-weight, human endogenous cancer regulatory factors of the present invention are obtained by growing human monocytic cells or cloned strains therefrom in a tissue culture medium to form human endogenous cancer regulatory factors having a molecular weight in the range from 50,000 to 92,000 and an isoelectric point in the pH range from 6.0 to 8.5, followed by treatment with a reducing agent and/or a protein denaturing agent.
ES550833A 1985-01-14 1986-01-13 Human endogenous cancer regulatory factors. Expired ES8705466A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP472185 1985-01-14
JP13667085 1985-06-21

Publications (2)

Publication Number Publication Date
ES8705466A1 true ES8705466A1 (en) 1987-05-01
ES550833A0 ES550833A0 (en) 1987-05-01

Family

ID=26338538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550833A Expired ES8705466A1 (en) 1985-01-14 1986-01-13 Human endogenous cancer regulatory factors.

Country Status (7)

Country Link
EP (1) EP0216929A1 (en)
KR (1) KR870700072A (en)
DK (1) DK436786A (en)
ES (1) ES8705466A1 (en)
NO (1) NO863657L (en)
PT (1) PT81823B (en)
WO (1) WO1986004069A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0193032A3 (en) * 1985-02-13 1988-04-06 Gesellschaft für Biotechnologische Forschung mbH (GBF) Composition comprising or containing cytokinin, process for its preparation, dna sequence and its use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204382L (en) * 1981-07-21 1983-01-22 Hayashibara Biochem Lab PUT TO MAKE MALCELLY FACTOR AND USE THEREOF
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin

Also Published As

Publication number Publication date
ES550833A0 (en) 1987-05-01
DK436786D0 (en) 1986-09-12
PT81823B (en) 1987-11-30
PT81823A (en) 1986-02-01
NO863657D0 (en) 1986-09-12
NO863657L (en) 1986-09-12
KR870700072A (en) 1987-02-28
EP0216929A1 (en) 1987-04-08
WO1986004069A1 (en) 1986-07-17
DK436786A (en) 1986-09-12

Similar Documents

Publication Publication Date Title
IT1203515B (en) SAPONINE COMPLEXES WITH PHOSPHOLIPIDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
MX9602259A (en) N-terminally chemically modified protein compositions and methods.
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
IT8547834A0 (en) PROCEDURE FOR TREATMENT OF CELLS WITH SOLUBLE BONE PROTEINS TO MAKE THEM SUITABLE FOR STIMULating THE GROWTH OF CARTILAGINE AND BONE TISSUES, AND THE PRODUCT OBTAINED
DE69024965D1 (en) DEHYDRODIDEMNIN B
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
DK168790D0 (en)
MY115211A (en) Novel amino acid derivatives, their preparation and use
TR199800811T2 (en) Stabilizing formulations for NGF.
IT1244879B (en) EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.
SE8500470L (en) COMPOSITIONS FOR COSMETIC, HEALTHY AND BODY-CONSERVATIVE USES
IL91184A0 (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
RU94045930A (en) Proteins, dna, vector, cell, methods of preparing and purification of protein, pharmaceutical composition
HU895788D0 (en) Process for producing peptides and medical products containing them
ES8705466A1 (en) Human endogenous cancer regulatory factors.
ES8606898A1 (en) Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same.
ES2018726A6 (en) PROCEDURE FOR PREPARING MITOMYCINE DERIVATIVES.
EP0136093A3 (en) Anti-cancer factors
FR2321298A1 (en) Compsns. with species-specific interferon activity - prepd. by incubating the appropriate messenger RNA in a cell-free medium
SU1387399A1 (en) NUTRIENT FOR CULTIVATION OF LEPTOSPIR
ES2106858T3 (en) NEW DERIVATIVES OF CYTARABINE, ITS PREPARATION PROCEDURE AND ITS USE AGAINST CANCER DISEASES.
GR1002969B (en) Medicinal preparation based on fetal cell suspension, having immune substituting effect and method of treatment of acquired immune deficiency syndrome (HIV infection) with the use of said preparation.